387 related articles for article (PubMed ID: 26115946)
41. Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.
Kim BH; Chung YH; Woo TG; Kang SM; Park S; Park BJ
Cells; 2023 Sep; 12(18):. PubMed ID: 37759521
[TBL] [Abstract][Full Text] [Related]
42. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
J Virol; 2018 May; 92(9):. PubMed ID: 29491162
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
Khanal S; Schank M; El Gazzar M; Moorman JP; Yao ZQ
Cells; 2021 Feb; 10(2):. PubMed ID: 33672138
[TBL] [Abstract][Full Text] [Related]
44. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.
McClintock D; Ratner D; Lokuge M; Owens DM; Gordon LB; Collins FS; Djabali K
PLoS One; 2007 Dec; 2(12):e1269. PubMed ID: 18060063
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
Messner M; Ghadge SK; Goetsch V; Wimmer A; Dörler J; Pölzl G; Zaruba MM
PLoS One; 2018; 13(4):e0196739. PubMed ID: 29702688
[TBL] [Abstract][Full Text] [Related]
46. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
Lo Cicero A; Nissan X
Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
[TBL] [Abstract][Full Text] [Related]
47. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
48. Embryonic expression of the common progeroid lamin A splice mutation arrests postnatal skin development.
McKenna T; Rosengardten Y; Viceconte N; Baek JH; Grochová D; Eriksson M
Aging Cell; 2014 Apr; 13(2):292-302. PubMed ID: 24305605
[TBL] [Abstract][Full Text] [Related]
49. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
Huang S; Chen L; Libina N; Janes J; Martin GM; Campisi J; Oshima J
Hum Genet; 2005 Dec; 118(3-4):444-50. PubMed ID: 16208517
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Latency and Eradication: Past, Present and Future.
Datta PK; Kaminski R; Hu W; Pirrone V; Sullivan NT; Nonnemacher MR; Dampier W; Wigdahl B; Khalili K
Curr HIV Res; 2016; 14(5):431-441. PubMed ID: 27009094
[TBL] [Abstract][Full Text] [Related]
51. Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.
Saxena S; Kumar S
Geroscience; 2020 Apr; 42(2):467-494. PubMed ID: 32048129
[TBL] [Abstract][Full Text] [Related]
52. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
[TBL] [Abstract][Full Text] [Related]
53. Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes.
Hilton BA; Liu J; Cartwright BM; Liu Y; Breitman M; Wang Y; Jones R; Tang H; Rusinol A; Musich PR; Zou Y
FASEB J; 2017 Sep; 31(9):3882-3893. PubMed ID: 28515154
[TBL] [Abstract][Full Text] [Related]
54. Longwave UV light induces the aging-associated progerin.
Takeuchi H; Rünger TM
J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
[TBL] [Abstract][Full Text] [Related]
55. Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome.
Puttaraju M; Jackson M; Klein S; Shilo A; Bennett CF; Gordon L; Rigo F; Misteli T
Nat Med; 2021 Mar; 27(3):526-535. PubMed ID: 33707772
[TBL] [Abstract][Full Text] [Related]
56. Antagonistic functions of LMNA isoforms in energy expenditure and lifespan.
Lopez-Mejia IC; de Toledo M; Chavey C; Lapasset L; Cavelier P; Lopez-Herrera C; Chebli K; Fort P; Beranger G; Fajas L; Amri EZ; Casas F; Tazi J
EMBO Rep; 2014 May; 15(5):529-39. PubMed ID: 24639560
[TBL] [Abstract][Full Text] [Related]
57. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging?
Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II
Front Genet; 2019; 10():455. PubMed ID: 31156709
[TBL] [Abstract][Full Text] [Related]
58. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
[TBL] [Abstract][Full Text] [Related]
59. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
Elife; 2015 Aug; 4():. PubMed ID: 26312502
[TBL] [Abstract][Full Text] [Related]
60. The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL; Marsili G; Battistini A; Sgarbanti M
Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]